<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.optometrytimes.com/view/tearsolutions-advances-lacripep-into-phase-2-following-dual-fda-designations-in-neurotrophic-keratitis</loc><lastmod>2026-06-03T17:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T17:00:00Z</news:publication_date>
        <news:title><![CDATA[TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/recent-study-findings-may-prove-previous-estimations-of-retinal-cell-communication-low-light-vision</loc><lastmod>2026-06-03T14:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Recent study findings may prove previous estimations of retinal cell communication, low-light vision]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/hybrid-ai-model-distinguishes-keratoconus-from-healthy-eyes-with-90-accuracy</loc><lastmod>2026-06-03T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Hybrid AI model distinguishes keratoconus from healthy eyes with 90% accuracy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/georgia-university-receives-state-funding-for-state-s-first-college-of-optometry</loc><lastmod>2026-06-02T14:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Georgia university receives state funding for state's first college of optometry]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/bausch-lomb-launches-preservative-free-version-of-blink-triple-care-eye-drops</loc><lastmod>2026-06-02T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Bausch + Lomb launches preservative-free version of Blink Triple Care eye drops]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/outlook-therapeutics-resubmits-bla-for-bevacizumab-vikg-ons-5010-lytenava-</loc><lastmod>2026-06-01T21:30:00Z</lastmod><news:news><news:publication_date>2026-06-01T21:30:00Z</news:publication_date>
        <news:title><![CDATA[Outlook Therapeutics resubmits BLA for bevacizumab-vikg (ONS-5010/Lytenava)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/from-paper-clinic-ep-4-retire-artificial-tears-updated-terms-eye-care</loc><lastmod>2026-06-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[From Paper to Clinic, Episode 4: Retire 'Artificial Tears': A Call for Updated Terminology in Eye Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/exercise-for-the-prevention-and-mitigation-of-eye-disease</loc><lastmod>2026-06-01T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Exercise for the prevention and mitigation of eye disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-independent-advantage-s01-recap-how-to-improve-your-comanagement-relationships</loc><lastmod>2026-05-29T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T19:00:00Z</news:publication_date>
        <news:title><![CDATA[The Independent Advantage S01 recap: How to improve your comanagement relationships]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/balance-ophthalmics-fda-510-k-clearance-wireless-enabled-nocturnal-iop-device</loc><lastmod>2026-05-29T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Balance Ophthalmics receives FDA 510(k) clearance for wireless-enabled nocturnal IOP device]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/study-tear-meibum-lipid-profiles-remain-stable-throughout-day-healthy-adult-patients</loc><lastmod>2026-05-28T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Study: Tear and meibum lipid profiles remain stable throughout day in healthy adult patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/fda-grants-appeal-for-bevacizumab-vikg-bla-in-neovascular-amd</loc><lastmod>2026-05-27T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T17:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA grants appeal for bevacizumab-vikg BLA in neovascular AMD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/drinking-habit-linked-to-faster-presbyopia-progression-in-men-study-finds</loc><lastmod>2026-05-27T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Drinking habit linked to faster presbyopia progression in men, study finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/upsher-smith-launches-generic-cyclosporine-ophthalmic-emulsion-for-dry-eye</loc><lastmod>2026-05-26T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Upsher-Smith launches generic cyclosporine ophthalmic emulsion for dry eye]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/ai-models-show-promise-but-face-significant-hurdles-in-predicting-glaucoma-progression-review-finds</loc><lastmod>2026-05-26T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T17:00:00Z</news:publication_date>
        <news:title><![CDATA[AI models show promise but face significant hurdles in predicting glaucoma progression, review finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/practical-tips-and-tricks-myopia-management-advice-for-peers</loc><lastmod>2026-05-26T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Practical tips and tricks: Myopia management advice for peers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/ai-and-eye-disease-research-has-grown-rapidly-since-2015-bibliometric-study-finds</loc><lastmod>2026-05-25T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-25T17:00:00Z</news:publication_date>
        <news:title><![CDATA[AI and eye disease research has grown rapidly since 2015, bibliometric study finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/macular-pigment-and-functional-vision-in-the-elderly</loc><lastmod>2026-05-25T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-25T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Macular pigment and functional vision in older patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/contact-lens-device-delivers-brain-stimulation-in-preclinical-depression-study</loc><lastmod>2026-05-22T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Contact lens device delivers brain stimulation in preclinical depression study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/practical-tips-and-tricks-real-world-advice-for-peers-when-treating-glaucoma</loc><lastmod>2026-05-22T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Practical tips and tricks: Real world advice for peers when treating glaucoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/spinach-derived-nanoparticles-outperform-cyclosporine-a-in-preclinical-dry-eye-m</loc><lastmod>2026-05-21T19:00:33.130Z</lastmod><news:news><news:publication_date>2026-05-21T19:00:33.130Z</news:publication_date>
        <news:title><![CDATA[Spinach-derived nanoparticles outperform cyclosporine A in preclinical dry eye models]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/reactive-to-proactive-the-case-for-earlier-interventional-glaucoma-management</loc><lastmod>2026-05-21T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Reactive to proactive: The case for earlier interventional glaucoma management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/practical-tips-and-tricks-peer-advice-for-identifying-the-glaucoma-suspect-and-first-line-approaches</loc><lastmod>2026-05-21T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Practical tips and tricks: Peer advice for identifying the glaucoma suspect and first line approaches]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/study-links-sleeve-gastrectomy-to-changes-in-corneal-and-lens-transparency</loc><lastmod>2026-05-20T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Study links sleeve gastrectomy to changes in corneal and lens transparency]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/bausch-lomb-launches-preservision-areds3-eye-vitamins-in-us</loc><lastmod>2026-05-20T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Bausch + Lomb launches PreserVision AREDS3 eye vitamins in US]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/case-study-superior-orbital-fissure-syndrome-caused-by-herpes-zoster</loc><lastmod>2026-05-20T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Case study: Superior orbital fissure syndrome caused by herpes zoster]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/avacincaptad-pegol-analysis-links-ga-treatment-to-preserved-driving-vision</loc><lastmod>2026-05-19T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Avacincaptad pegol analysis links GA treatment to preserved driving vision]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-anti-inflammatory-agents-and-refractive-development-in-children</loc><lastmod>2026-05-19T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: Anti-inflammatory agents and refractive development in children]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/study-finds-short-term-corticosteroids-do-not-raise-iop-in-adults-with-atopic-dermatitis</loc><lastmod>2026-05-18T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Study finds short-term corticosteroids do not raise IOP in adults with atopic dermatitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-renaming-artificial-tears</loc><lastmod>2026-05-18T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T19:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: Renaming artificial tears]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/ischemic-retinal-disorders-what-to-know-and-look-for</loc><lastmod>2026-05-18T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Ischemic retinal disorders: What to know and look for]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/practical-tips-and-tricks-advice-for-peers-when-treating-the-myopic-pediatric-patient</loc><lastmod>2026-05-15T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Practical tips and tricks: Advice for peers when treating the myopic pediatric patient]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/filling-the-gap-in-scleral-lens-application-with-scleralease</loc><lastmod>2026-05-15T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Filling the gap in scleral lens application with ScleralEase]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-contact-lens-wear-increasing-among-university-students-study-suggests</loc><lastmod>2026-05-14T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: Contact lens wear increasing among university students, study suggests]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/sequel-pal-linked-to-reduced-digital-eye-strain-after-6-weeks-of-wear</loc><lastmod>2026-05-13T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-13T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Sequel PAL linked to reduced digital eye strain after 6 weeks of wear]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/intracortical-visual-prosthesis-a-new-chapter-in-advancing-visual-restoration</loc><lastmod>2026-05-13T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-13T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Intracortical visual prosthesis: A new chapter in advancing visual restoration ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-diet-affect-on-amd-progression</loc><lastmod>2026-05-12T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-12T17:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: Diet and its affect on AMD progression]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-ai-screening-for-psychological-distress-in-glaucoma-clinics</loc><lastmod>2026-05-12T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-12T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: AI screening for psychological distress in glaucoma clinics]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/practical-tips-and-tricks-dry-eye-treatment-advice-for-peers</loc><lastmod>2026-05-11T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-11T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Practical tips and tricks: Dry eye treatment advice for peers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/keeping-dry-eye-in-the-differential-diagnosis-and-management-plan-when-suspecting-allergic-conjunctivitis</loc><lastmod>2026-05-11T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-11T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Keeping dry eye in the differential diagnosis and management plan when suspecting allergic conjunctivitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/latinos-en-optometry-addresses-vision-symptoms-linked-to-tbi</loc><lastmod>2026-05-08T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-08T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Latinos en Optometry addresses vision symptoms linked to TBI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/syd-101-s-crl-a-shifting-of-fda-goalposts</loc><lastmod>2026-05-08T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-08T10:00:00Z</news:publication_date>
        <news:title><![CDATA[SYD-101's CRL: A shifting of FDA goalposts]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/latinos-en-optometry-expands-early-career-awareness-with-new-student-tool</loc><lastmod>2026-05-07T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-07T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Latinos en Optometry expands early career awareness with new student tool]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-the-natural-history-of-ted</loc><lastmod>2026-05-07T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-07T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: The natural history of TED]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-dot-lenses-show-reduced-myopia-progression-in-children-after-2-years</loc><lastmod>2026-05-06T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-06T21:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: DOT lenses show reduced myopia progression in children after 2 years]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-a-non-invasive-tool-to-study-the-eye-heart-relationship</loc><lastmod>2026-05-06T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-06T19:00:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: A non-invasive tool to study the eye-heart relationship]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-independent-advantage-s01-e05-comanagement-as-a-two-way-street</loc><lastmod>2026-05-06T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-06T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The Independent Advantage S01 E05: Comanagement as a two-way street]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/arvo-2026-miyosmart-iq-demonstrates-myopia-control-in-children-as-young-as-aged-4</loc><lastmod>2026-05-05T21:05:00Z</lastmod><news:news><news:publication_date>2026-05-05T21:05:00Z</news:publication_date>
        <news:title><![CDATA[ARVO 2026: MiYOSMART iQ demonstrates myopia control in children as young as aged 4]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/study-low-dose-eye-drops-manage-adult-myopia-for-24-hours</loc><lastmod>2026-05-05T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-05T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Study: Low-dose eye drops manage adult myopia for 24 hours ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/from-paper-clinic-ep-3-ai-eye-care-retinopathy-clinic-future</loc><lastmod>2026-05-04T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-04T12:00:00Z</news:publication_date>
        <news:title><![CDATA[From Paper to Clinic, Episode 3: AI in Eye Care: From Diabetic Retinopathy to the Clinic of the Future]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/when-structure-and-symptoms-don-t-align-using-erg-to-clarify-the-glaucoma-suspect</loc><lastmod>2026-05-04T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-04T10:00:00Z</news:publication_date>
        <news:title><![CDATA[When structure and symptoms don’t align: Using ERG to clarify the glaucoma suspect]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/nei-study-links-glucose-metabolism-to-gene-control-in-retinal-photoreceptors</loc><lastmod>2026-05-01T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-01T10:00:00Z</news:publication_date>
        <news:title><![CDATA[NEI study links glucose metabolism to gene control in retinal photoreceptors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/b-vitamin-supplementation-potential-slowing-amd-progression-narrative-review</loc><lastmod>2026-04-30T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-30T14:00:00Z</news:publication_date>
        <news:title><![CDATA[B vitamin supplementation shows potential in slowing AMD progression in narrative review]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/menopause-s-impact-on-presbyopia-and-eye-health-with-dr-jessica-crooker</loc><lastmod>2026-04-30T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-30T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Menopause's impact on presbyopia and eye health with Dr Jessica Crooker]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/wco-alcon-video-series-breaks-down-tfos-dews-iii-dry-eye-report</loc><lastmod>2026-04-29T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T19:00:00Z</news:publication_date>
        <news:title><![CDATA[WCO, Alcon video series breaks down TFOS DEWS III Dry Eye Report]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/new-version-of-chatgpt-launches-for-clinicians</loc><lastmod>2026-04-29T17:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T17:00:00Z</news:publication_date>
        <news:title><![CDATA[New version of ChatGPT launches for clinicians]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/research-highlights-guide-dogs-decision-making-in-supporting-visually-impaired-handlers</loc><lastmod>2026-04-29T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Research highlights guide dogs’ decision-making in supporting visually-impaired handlers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-independent-advantage-s01-e04-changing-comanagement-culture</loc><lastmod>2026-04-29T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The Independent Advantage S01 E04: Changing comanagement culture]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/free-near-glasses-improve-productivity-and-roi-in-indian-garment-factories</loc><lastmod>2026-04-28T19:50:00Z</lastmod><news:news><news:publication_date>2026-04-28T19:50:00Z</news:publication_date>
        <news:title><![CDATA[Free near glasses improve productivity and ROI in Indian garment factories]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/contact-lens-misuse-water-you-thinking-</loc><lastmod>2026-04-28T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-28T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Contact lens misuse: Water you thinking?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-perimenopause-menopause-intersection-with-presbyopia</loc><lastmod>2026-04-27T17:00:00Z</lastmod><news:news><news:publication_date>2026-04-27T17:00:00Z</news:publication_date>
        <news:title><![CDATA[The perimenopause/menopause intersection with presbyopia]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-oculomics-paradigm-a-comprehensive-review</loc><lastmod>2026-04-27T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-27T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The oculomics paradigm: A comprehensive review ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/bausch-lomb-reports-nearly-725-000-pounds-of-eye-care-product-materials-recycled-by-company</loc><lastmod>2026-04-24T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-24T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Bausch + Lomb reports nearly 725,000 pounds of eye care product materials recycled by company]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/how-to-combat-accessibility-challenges-in-refractive-error-services-with-noelle-whitestone</loc><lastmod>2026-04-24T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-24T10:00:00Z</news:publication_date>
        <news:title><![CDATA[How to combat accessibility challenges in refractive error services with Noelle Whitestone]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/lenz-therapeutics-submits-maa-for-vizz-to-uk-s-medicines-and-healthcare-products-regulatory-agency</loc><lastmod>2026-04-23T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-23T14:00:00Z</news:publication_date>
        <news:title><![CDATA[LENZ Therapeutics submits MAA for Vizz to UK’s Medicines and Healthcare Products Regulatory Agency]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/imagine-the-possibilities-what-the-syd-101-crl-means-for-myopia-care</loc><lastmod>2026-04-23T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-23T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Imagine the possibilities: What the SYD-101 CRL means for myopia care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/systemic-review-finds-women-still-face-barriers-to-refractive-error-correction</loc><lastmod>2026-04-22T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-22T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Systemic review finds women still face barriers to refractive error correction]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/bostonsight-expands-scleral-lens-options-outlines-5-year-strategy-for-global-access</loc><lastmod>2026-04-22T17:00:00Z</lastmod><news:news><news:publication_date>2026-04-22T17:00:00Z</news:publication_date>
        <news:title><![CDATA[BostonSight expands scleral lens options, outlines 5-year strategy for global access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-independent-advantage-s01-e03-stress-testing-potential-comanagement-relationships-from-the-md-s-chair</loc><lastmod>2026-04-22T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-22T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The Independent Advantage S01 E03: Stress-testing potential comanagement relationships from the MD’s chair]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/intravitreal-vamikibart-shows-visual-and-anatomical-improvements-in-uveitic-macular-edema-study</loc><lastmod>2026-04-21T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-21T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Intravitreal vamikibart shows visual and anatomical improvements in uveitic macular edema study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/glaukos-epioxa-for-keratoconus-receives-permanent-j-code-effective-summer-2026</loc><lastmod>2026-04-21T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-21T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Glaukos’ Epioxa for keratoconus receives permanent J-code effective summer 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/study-demonstrates-0-025-atropine-balancing-efficacy-and-tolerability-in-chinese-pediatric-patients</loc><lastmod>2026-04-20T21:30:00Z</lastmod><news:news><news:publication_date>2026-04-20T21:30:00Z</news:publication_date>
        <news:title><![CDATA[Study demonstrates 0.025% atropine balancing efficacy and tolerability in Chinese pediatric patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/modular-shape-changing-iol-presbyopia-improves-vision-36-months-study-finds</loc><lastmod>2026-04-20T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-20T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Modular, shape-changing IOL for presbyopia improves vision at 36 months, study finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/motugivatrep-eye-drops-for-ded-launch-in-japan</loc><lastmod>2026-04-17T22:00:00Z</lastmod><news:news><news:publication_date>2026-04-17T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Motugivatrep eye drops for DED launch in Japan]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/study-patients-with-dual-sensory-impairment-less-likely-to-functionally-improve-post-vision-rehab</loc><lastmod>2026-04-17T19:00:00Z</lastmod><news:news><news:publication_date>2026-04-17T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Patients with dual sensory impairment are less likely to functionally improve post vision rehab]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/study-smoking-doubles-risk-of-major-vision-threatening-eye-diseases</loc><lastmod>2026-04-16T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-16T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Study: Smoking doubles risk of major vision-threatening eye diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/aurion-biotech-doses-first-patients-astra-phase-3-study-evaluating-investigational-corneal-endothelial-cell-therapy</loc><lastmod>2026-04-16T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-16T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Aurion Biotech doses first patients in ASTRA phase 3 study evaluating investigational corneal endothelial cell therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/meta-analysis-links-outdoor-activity-to-lower-myopia-risk-in-chinese-pediatric-patients</loc><lastmod>2026-04-15T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-15T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Meta-analysis links outdoor activity to lower myopia risk in Chinese pediatric patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-independent-advantage-s01-e02-what-ods-should-bring-to-the-comanagement-table</loc><lastmod>2026-04-15T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-15T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The Independent Advantage S01 E02: What ODs should bring to the comanagement table]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/fda-expands-faricimab-label-macular-edema-secondary-rvo-beyond-6-months</loc><lastmod>2026-04-14T17:00:00Z</lastmod><news:news><news:publication_date>2026-04-14T17:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA expands faricimab label to include treatment of macular edema secondary to RVO beyond 6 months]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/first-in-human-technology-unveiled-at-ascrs-2026-enables-real-time-outflow-measurement-during-glaucoma-surgery</loc><lastmod>2026-04-14T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-14T14:00:00Z</news:publication_date>
        <news:title><![CDATA[First-in-human technology unveiled at ASCRS 2026, enables real-time outflow measurement during glaucoma surgery]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/treating-dry-eye-before-during-and-after-cataract-and-refractive-surgery</loc><lastmod>2026-04-14T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-14T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Treating dry eye before, during, and after cataract and refractive surgery]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/key-updates-ascrs-preoperative-ocular-surface-disease-algorithm</loc><lastmod>2026-04-13T17:00:00Z</lastmod><news:news><news:publication_date>2026-04-13T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Key updates on the ASCRS preoperative ocular surface disease algorithm]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/tecnis-eyhance-iol-reaches-10-million-implant-milestone</loc><lastmod>2026-04-13T15:00:00Z</lastmod><news:news><news:publication_date>2026-04-13T15:00:00Z</news:publication_date>
        <news:title><![CDATA[TECNIS Eyhance IOL reaches 10 million-implant milestone]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/almost-half-of-patients-would-switch-providers-for-financial-convenience-study-finds</loc><lastmod>2026-04-13T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-13T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Almost half of patients would switch providers for financial convenience, study finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/coopervision-launches-made-better-promise-a-new-global-sustainability-platform</loc><lastmod>2026-04-10T17:00:00Z</lastmod><news:news><news:publication_date>2026-04-10T17:00:00Z</news:publication_date>
        <news:title><![CDATA[CooperVision launches MADE BETTER Promise, a new global sustainability platform ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/teprotumumab-trbw-tepezza-found-to-have-efficacy-comparable-to-intravenous-treatment-in-phase-3-trial</loc><lastmod>2026-04-10T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-10T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Teprotumumab-trbw (Tepezza) found to have efficacy comparable to intravenous treatment in phase 3 trial ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/the-independent-advantage-s01-e01-communication-building-blocks-comanagement</loc><lastmod>2026-04-09T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-09T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The Independent Advantage S01 E01: Communication as the building blocks of comanagement]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/directional-oct-provides-biomarkers-parkinson-disease-outer-retina</loc><lastmod>2026-04-08T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-08T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Directional OCT provides biomarkers of Parkinson disease in the outer retina]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/researchers-develop-experimental-living-eye-drop-for-corneal-wound-repair</loc><lastmod>2026-04-07T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-07T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Researchers develop experimental “living eye drop” for corneal wound repair]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/from-paper-clinic-ep-2-geographic-atrophy-peripheral-retinal-disease</loc><lastmod>2026-04-06T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-06T12:00:00Z</news:publication_date>
        <news:title><![CDATA[From Paper to Clinic, Episode 2: Is Geographic Atrophy a Peripheral Retinal Disease?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/low-dose-atropine-after-the-fda-crl-a-setback-or-a-catalyst-for-precision-myopia-pharmacotherapy-</loc><lastmod>2026-04-06T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-06T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Low-dose atropine after the FDA CRL: A setback or a catalyst for precision myopia pharmacotherapy?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/iantrek-s-allospan-canal-makes-way-into-us-site-evaluations</loc><lastmod>2026-04-03T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-03T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Iantrek's AlloSpan Canal makes way into US site evaluations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/menopause-and-the-eye-practical-considerations-optometric-care</loc><lastmod>2026-04-02T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-02T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Menopause and the eye: Practical considerations for optometric care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/less-myopic-progression-seen-in-pediatric-patients-tapered-off-low-dose-atropine-compared-with-stopping-atropine</loc><lastmod>2026-04-01T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-01T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Less myopic progression seen in pediatric patients tapered off low-dose atropine compared with stopping atropine]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/elegrobart-meets-primary-end-points-clinically-meaningful-proptosis-responder-rate-in-phase-3-topline-reveal-1-trial</loc><lastmod>2026-03-31T19:00:00Z</lastmod><news:news><news:publication_date>2026-03-31T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Elegrobart meets primary end points, clinically-meaningful proptosis responder rate in phase 3 topline REVEAL-1 trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/health-canada-approves-clobetasol-propionate-ophthalmic-suspension-0-05-for-post-op-inflammation-and-pain</loc><lastmod>2026-03-31T14:00:00Z</lastmod><news:news><news:publication_date>2026-03-31T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Health Canada approves clobetasol propionate ophthalmic suspension 0.05% for post–op inflammation and pain]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/why-we-need-more-tools-in-our-toolkit-for-myopia-progression</loc><lastmod>2026-03-31T10:00:00Z</lastmod><news:news><news:publication_date>2026-03-31T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Why we need more tools in our tool kit for myopia progression]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/yuvezzi-carbachol-brimonidine-tartrate-ophthalmic-solution-available-us-presbyopia-treatment</loc><lastmod>2026-03-30T17:00:00Z</lastmod><news:news><news:publication_date>2026-03-30T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Yuvezzi (carbachol/brimonidine tartrate ophthalmic solution) is now commercially available in the US for presbyopia treatment]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.optometrytimes.com/view/combating-your-patient-s-confusion-about-their-medicaid-medicare-coverage</loc><lastmod>2026-03-30T10:00:00Z</lastmod><news:news><news:publication_date>2026-03-30T10:00:00Z</news:publication_date>
        <news:title><![CDATA[Combating your patients' confusion about their Medicaid/Medicare coverage]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>